Migraine: open trials in Israel

• NCT07609914

  A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine

  Trial Treatment · Phase 4 · Pfizer

  Shaare Zedek Medical Center, Jerusalem · Sheba medical center, Ramat Gan · Sourasky Medical Center, Tel Aviv

  Registry updated 2026-10-14

• NCT07729462

  A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine

  Trial Treatment · Phase 3 · Pfizer

  Shaare Zedek Medical Center, Jerusalem · Sourasky Medical Center, Tel Aviv

  Registry updated 2026-10-14

• NCT05711394

  A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

  Trial Treatment · Phase 3 · AbbVie

  Shamir Medical Center /ID# 256857, Beer Ya'akov · Hillel Yaffe Medical Center /ID# 246747, Hadera · Bnai Zion Medical Center /ID# 247469, Haifa · The Chaim Sheba Medical Center /ID# 246746, Ramat Gan · Tel Aviv Sourasky Medical Center /ID# 247466, Tel Aviv

  Registry updated 2026-10-06

• NCT07841509

  The Effect of Remote Electrical Neuromodulation (REN) on Conditioned Pain Modulation (CPM) in Migraine and Fibromyalgia

  Trial Treatment · Theranica

  Rambam Health Care Campus, Haifa

  Registry updated 2026-09-25

• NCT05707949

  Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine

  Trial Treatment · Phase 3 · AbbVie

  Shamir Medical Center /ID# 256858, Beer Ya'akov · Hillel Yaffe Medical Center /ID# 248923, Hadera · Bnai Zion Medical Center /ID# 251132, Haifa · The Chaim Sheba Medical Center /ID# 248990, Ramat Gan · Tel Aviv Sourasky Medical Center /ID# 251133, Tel Aviv

  Registry updated 2025-08-11

All Migraine trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error